NDRA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
ENDRA Life Sciences Inc (NDRA) is not a good buy at the moment for a beginner, long-term investor. The lack of positive financial performance, absence of trading signals, and no significant news or catalysts make this stock less attractive. Additionally, technical indicators and trading trends do not suggest a strong entry point.
The MACD is above 0 and positively contracting, indicating slight bullish momentum. However, the RSI at 79.391 is in the neutral zone, and moving averages are converging, which suggests no clear trend. The stock is trading near its R1 resistance level of 5.29, which could act as a ceiling for further price increases. Historical patterns suggest a potential short-term decline.
NULL identified. No recent news or significant trading trends.
The company's financial performance is weak, with declining net income (-23.62% YoY) and EPS (-62.94% YoY). No significant insider or hedge fund activity. Technical indicators suggest limited upside potential.
In Q4 2025, revenue remained at 0 with no growth. Net income dropped significantly (-23.62% YoY), and EPS declined sharply (-62.94% YoY). Gross margin remained at 0 with no improvement.
No analyst rating or price target data available.
